Windtree Therapeutics Valuation
| WINT Stock | USD 0.13 0.00 0.00% |
Windtree Therapeutics seems to be undervalued based on Macroaxis valuation methodology. Our model calculates the value of Windtree Therapeutics from examining the company fundamentals such as Return On Asset of -0.45, current valuation of 917.64 K, and Shares Owned By Insiders of 0.27 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Windtree Therapeutics' valuation include:
Price Book 0.2732 | Enterprise Value | Enterprise Value Ebitda 0.0088 | Price Sales 660.5268 | Forward PE 0.3652 |
Undervalued
Today
Please note that Windtree Therapeutics' price fluctuation is dangerous at this time. Calculation of the real value of Windtree Therapeutics is based on 3 months time horizon. Increasing Windtree Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Windtree Therapeutics' intrinsic value may or may not be the same as its current market price of 0.13, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.13 | Real 1.85 | Target 7.0 | Hype 0.094 | Naive 0.0595 |
The intrinsic value of Windtree Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Windtree Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Windtree Therapeutics helps investors to forecast how Windtree stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Windtree Therapeutics more accurately as focusing exclusively on Windtree Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Windtree Therapeutics' intrinsic value based on its ongoing forecasts of Windtree Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Windtree Therapeutics' closest peers.
Windtree Therapeutics Cash |
|
Windtree Valuation Trend
Windtree Therapeutics' real value is important for investors to make better decisions and a more accurate overall view of Windtree Therapeutics' financial worth over time. Using both Windtree Therapeutics' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Windtree Therapeutics Total Value Analysis
Windtree Therapeutics is at this time estimated to have valuation of 917.64 K with market capitalization of 4.92 M, debt of 16.83 M, and cash on hands of 11.38 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Windtree Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
917.64 K | 4.92 M | 16.83 M | 11.38 M |
Windtree Therapeutics Asset Utilization
One of the ways to look at asset utilization of Windtree is to check how much profit was generated for every dollar of assets it reports. Windtree Therapeutics maintains a negative usage of resources of -0.45 (%), losing $0.004476 for each dollar of resources held by the company. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it maintains. Specifically, asset utilization of Windtree Therapeutics shows how discouraging it operates for each dollar spent on its resources.Windtree Therapeutics Ownership Allocation
Roughly 99.14 (%) of Windtree Therapeutics outstanding shares are held by general public with 0.27 % owned by insiders and only 0.59 percent by institutional investors.Windtree Therapeutics Profitability Analysis
Net Loss for the year was (20.29 M) with loss before overhead, payroll, taxes, and interest of (17.79 M).About Windtree Therapeutics Valuation
The stock valuation mechanism determines Windtree Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Windtree Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Windtree Therapeutics. We calculate exposure to Windtree Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Windtree Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -94.3 K | -99 K | |
| Pretax Profit Margin | (124.89) | (131.13) | |
| Operating Profit Margin | (144.58) | (137.35) | |
| Net Loss | (173.44) | (164.77) | |
| Gross Profit Margin | 0.84 | 0.88 |
Windtree Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Windtree Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 220 K | |
| Forward Price Earnings | 0.3652 |
Windtree Therapeutics Current Valuation Indicators
Windtree Therapeutics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Windtree Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Windtree Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Windtree Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Windtree Therapeutics' worth.Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.